Tag: United States
MSD appoints Brecht Vanneste as Managing Director of India
Brecht is a biopharmaceutical industry veteran who has been at MSD for more than 27 years, and has held a portfolio of international leadership roles
Trump’s NIH funding cuts & freezes raise concerns over US biotech...
According to GlobalData’s Pharma Intelligence Center Grants Database, SBIR and STTR grants involving innovator drugs saw a 37% increase in total grant value from $237 million in 2020 to $326 million in 2024
Biocon Biologics obtains US-FDA approval for biosimilar Aflibercept for Yesafili
A significant milestone for the company marking its entry into ophthalmology, a new therapeutic area in the United States
In a first, Amul to produce & launch its fresh milk...
This partnership between the two cooperatives will bring the Amul to millions of Americans through its branded fresh milk products in the United States using MMPA's superior technology
Cipla enters into JV with Kemwell Biopharma & Manipal Education &...
The primary goal of this joint venture is to develop and commercialize novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Biocon Biologics launches biosimilar ‘Hulio’ in USA
HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab) has been introduced in the United States after five years of experience in Europe and two years in Canada.
AMPATH launches its pathology laboratory in Mumbai
The lab has collaborated with UPMC, one of the top ranked hospitals in the United States, which allows them to work with the world’s leading clinicians to help them ensure customers comprehensive services that reflect precision and accuracy in every test conducted..........................
Bharat Biotech clarifies on the US-FDA’s EUA denial for COVAXIN
As per Bharat Biotech, its US partner, Ocugen has received a recommendation from the FDA to pursue Biologics License Applications (BLA) path for COVAXIN, which is full approval instead of EUA...................
Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules...
A calcineurin inhibitor, Tacrolimus has been particularly effective in treating patients of renal transplant for more than two decades..............
Piramal Pharma Solutions invests $10 million to expand its API ...
The enhanced capability opens the Michigan site up to a new base of customers, including the antibody drug conjugate (ADC) market.............................